Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
about
Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation
P2860
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@en
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@nl
type
label
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@en
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@nl
prefLabel
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@en
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.
@nl
P2093
P2860
P1476
Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
@en
P2093
Astrid Bouteau
Aurélie Snauwaert
Bruno Bouchet
Julien Jabot
Laure Corradi
Nicolas Allou
Pascal Augustin
Philippe Montravers
Richard Galliot
P2860
P2888
P356
10.1186/S13613-016-0211-Z
P577
2016-11-02T00:00:00Z
P6179
1002809586